How do you use Biotherapeutics in a sentence? See 10+ example sentences showing how this word appears in different contexts, plus the exact meaning.
Biotherapeutics in a sentence
Biotherapeutics meaning
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology.
Using Biotherapeutics
- The main meaning on this page is: The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology.
- In the example corpus, biotherapeutics often appears in combinations such as: atara biotherapeutics, iovance biotherapeutics, biotherapeutics by.
Context around Biotherapeutics
- Average sentence length in these examples: 19.1 words
- Position in the sentence: 6 start, 14 middle, 0 end
- Sentence types: 20 statements, 0 questions, 0 exclamations
Corpus analysis for Biotherapeutics
- In this selection, "biotherapeutics" usually appears in the middle of the sentence. The average example has 19.1 words, and this corpus slice is mostly made up of statements.
- Around the word, iovance, arcutis, atara, higher, makes and stock stand out and add context to how "biotherapeutics" is used.
- Recognizable usage signals include 935 to biotherapeutics inc located and and commercializes biotherapeutics for the. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "biotherapeutics" sits close to words such as abrasion, abscess and aced, which helps place it inside the broader word index.
Example types with biotherapeutics
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
Bolt Biotherapeutics stock opened at $0.83 on Wednesday. (9 words)
Sensei Biotherapeutics) just reported results for the first quarter of 2024. (11 words)
State Street Corp raised its holdings in Atara Biotherapeutics by 45.1% in the 1st quarter. (16 words)
The National Heart, Lung, and Blood Institute, one of the institutes that make up the National Institutes of Health, has awarded $355,935 to Biotherapeutics, Inc., located in Blacksburg, Virginia, for lung disease research as it relates to asthma. (39 words)
Needham & Company LLC reaffirmed a “buy” rating and issued a $18.00 target price on shares of Arcutis Biotherapeutics in a research report on Thursday, August 15th. (27 words)
Citigroup Inc.’s holdings in Arcutis Biotherapeutics were worth $1,972,000 as of its most recent filing with the Securities & Exchange Commission. (23 words)
Example sentences (20)
Given Iovance Biotherapeutics’ higher possible upside, analysts clearly believe Iovance Biotherapeutics is more favorable than Artiva Biotherapeutics.
Citigroup Inc.’s holdings in Arcutis Biotherapeutics were worth $1,972,000 as of its most recent filing with the Securities & Exchange Commission.
Endurant Capital Management LP acquired a new position in Iovance Biotherapeutics during the fourth quarter valued at approximately $451,000.
Finally, Mizuho lowered shares of Atara Biotherapeutics from a “buy” rating to a “neutral” rating in a report on Thursday, November 9th.
Finally, US Bancorp DE raised its position in Iovance Biotherapeutics by 72.7% in the 1st quarter.
State Street Corp raised its holdings in Atara Biotherapeutics by 45.1% in the 1st quarter.
Zymeworks Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer.
Barinthus Biotherapeutics makes up 14.8% of DC Funds LP’s investment portfolio, making the stock its 3rd biggest holding.
Bolt Biotherapeutics stock opened at $0.83 on Wednesday.
B. Riley Wealth Advisors Inc. bought a new stake in shares of Iovance Biotherapeutics during the 2nd quarter worth $107,000.
Envestnet Asset Management Inc. grew its holdings in shares of Iovance Biotherapeutics by 17.6% during the 1st quarter.
Kling Biotherapeutics is a clinical-stage, privately held biotech company focused on discovery and development of antibody based therapeutics.
Needham & Company LLC reaffirmed a “buy” rating and issued a $18.00 target price on shares of Arcutis Biotherapeutics in a research report on Thursday, August 15th.
On average, analysts anticipate that Arcutis Biotherapeutics will post -2.21 EPS for the current fiscal year.
Sensei Biotherapeutics) just reported results for the first quarter of 2024.
State Street Corp raised its position in Iovance Biotherapeutics by 4.6% during the third quarter.
The National Heart, Lung, and Blood Institute, one of the institutes that make up the National Institutes of Health, has awarded $355,935 to Biotherapeutics, Inc., located in Blacksburg, Virginia, for lung disease research as it relates to asthma.
XTX Topco Ltd lifted its position in Arcutis Biotherapeutics by 30.9% in the 3rd quarter.
Atara Biotherapeutics currently has a consensus rating of “Hold” and an average price target of $28.
Finally, Two Sigma Advisers LP raised its stake in shares of Atara Biotherapeutics by 24.9% during the 1st quarter.
Common combinations with biotherapeutics
These word pairs occur most frequently in English texts:
- atara biotherapeutics 10×
- iovance biotherapeutics 8×
- biotherapeutics by 7×
- biotherapeutics in 6×
- arcutis biotherapeutics 5×
- biotherapeutics inc 5×
- biotherapeutics during 3×
- biotherapeutics is 2×
- sensei biotherapeutics 2×
- ridgeback biotherapeutics 2×